Abivax S.A. (ABVX)
NASDAQ·Healthcare·Biotechnology
$96.74
-4.09%
Mkt Cap $7.19B
Analyst Ratings
No recent rating data.
Price Target (17 analysts)
$145.67
Range $110.00 – $176.00
Implied Upside
+50.6%
Consensus $145.67 vs current $96.74
NASDAQ·Healthcare·Biotechnology
$96.74
-4.09%
Mkt Cap $7.19B
No recent rating data.
Price Target (17 analysts)
$145.67
Range $110.00 – $176.00
+50.6%
Consensus $145.67 vs current $96.74